uniQure

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

1 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Global Markets & Equities Just now (03:39 AM IST)

uniQure Shares Tumble as Huntington’s Gene Therapy Data Undercut Investor Expectations

uniQure’s stock fell sharply after updated data from its Huntington’s disease gene therapy program failed to meet investor hopes, despite evidence the treatment may still slow disease progression over time. The reaction rippled beyond the company, with ClearPoint Neuro also sliding as markets reassessed the commercial and clinical outlook for the broader program.

By RDU Global Wire5 min read

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside uniQure:

Washington, D.C.(1)ClearPoint Neuro(1)